Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout

Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: Low-concentration Atropine for Myopia Progression (LAMP) Study

(2021) Fen Fen Li et al.   OPHTHALMOLOGY

Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study

(2021) Osamu Hieda et al.   JAPANESE JOURNAL OF OPHTHALMOLOGY

Atropine for treatment of childhood myopia in India (I-ATOM): multicentric randomized trial

(2021) Rohit Saxena et al.   OPHTHALMOLOGY

Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children: a pilot study

(2021) Lutz Joachimsen et al.   INTERNATIONAL OPHTHALMOLOGY

Myopia incidence and lifestyle changes among school children during the COVID-19 pandemic: a population-based prospective study

(2021) Xiujuan Zhang et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

A retrospective analysis of the therapeutic effects of 0.01% atropine on axial length growth in children in a real-life clinical setting

(2021) Hakan Kaymak et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

High prevalence of myopia in children and their parents in Hong Kong Chinese Population: the Hong Kong Children Eye Study

(2020) Jason C. Yam et al.   ACTA OPHTHALMOLOGICA

Western Australia Atropine for the Treatment of Myopia (WA‐ATOM) study: rationale, methodology, and participant baseline characteristics

(2020) Samantha S‐Y Lee et al.   CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine

(2020) Fen Fen Li et al.   OPHTHALMOLOGY

A 3-year follow-up study of atropine treatment for progressive myopia in Europeans

(2020) Jan Roelof Polling et al.   EYE

Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children

(2020) Shifei Wei et al.   JAMA Ophthalmology

Efficacy of atropine 0.01% for the treatment of childhood myopia in European patients

(2019) Matteo Sacchi et al.   ACTA OPHTHALMOLOGICA

Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)—study protocol

(2019) Augusto Azuara-Blanco et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study

(2019) Jason C. Yam et al.   OPHTHALMOLOGY

Update in myopia and treatment strategy of atropine use in myopia control

(2018) Pei-Chang Wu et al.   EYE

Low-Concentration Atropine for Myopia Progression (LAMP) Study

(2018) Jason C. Yam et al.   OPHTHALMOLOGY

The Lowdown on Low-Concentration Atropine for Myopia Progression

(2018) Padmaja Sankaridurg et al.   OPHTHALMOLOGY

The acceptability and visual impact of 0.01% atropine in a Caucasian population

(2016) James Loughman et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2

(2016) Audrey Chia et al.   OPHTHALMOLOGY

Atropine for the Treatment of Childhood Myopia: Changes after Stopping Atropine 0.01%, 0.1% and 0.5%

(2013) Audrey Chia et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Maximum Atropine Dose Without Clinical Signs or Symptoms

(2013) Jeffrey Cooper et al.   OPTOMETRY AND VISION SCIENCE

Myopia

(2012) Ian G Morgan et al.   LANCET

Atropine for the Treatment of Childhood Myopia: Safety and Efficacy of 0.5%, 0.1%, and 0.01% Doses (Atropine for the Treatment of Myopia 2)

(2011) Audrey Chia et al.   OPHTHALMOLOGY

Prevention of Myopia Onset with 0.025% Atropine in Premyopic Children

(2010) Po-Chiung Fang et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Development of a Chinese version of the National Eye Institute Visual Function Questionnaire (CHI-VFQ-25) as a tool to study patients with eye diseases in Hong Kong

(2009) C W S Chan et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Atropine for the Treatment of Childhood Myopia: Effect on Myopia Progression after Cessation of Atropine

(2009) Louis Tong et al.   OPHTHALMOLOGY